TALTZ (ixekizumab)

**Product type:** Human Prescription Drug

**Active ingredient:** IXEKIZUMAB

**Strength:** 20 mg/.25mL

**Dosage form:** Injection, Solution

**Route:** Subcutaneous

**Labeler:** Eli Lilly and Company

**Marketing category:** BLA (BLA125521)

**Pharmacologic class:** Interleukin-17A Antagonist [EPC], Interleukin-17A Antagonists [MoA]